# Peptide safety: UK warnings Canonical: https://europeanpeptideshop.com/blog/are-peptides-safe-uk/ Explore the catalogue and research library. Ordering and shipping have not opened yet. Research news · 8 November 2026 · 2 min read · By [European Peptide Shop](https://europeanpeptideshop.com/about/) ### On this page Are peptides safe? UK bodies give no single answer, because a licensed peptide medicine and an unregulated online product are different things. Regulators have assessed the first. They have not assessed the second. ## Are peptides safe when unregulated? The British College of Aesthetic Medicine (BCAM) warned about unregulated peptide injections in 2026. Its list of risks includes: - Immune or inflammatory reactions - Contamination or sterility failures - Incorrect dosing or inconsistent potency - Hormonal or metabolic disruption ## What has the MHRA said about fakes? After its [Birmingham raid](https://europeanpeptideshop.com/blog/mhra-birmingham-raid-fake-pens/) it said products sold as retatrutide outside legitimate clinical trials "could pose serious risks to public health". ## Are peptides safe according to UK clinicians? The Guardian reported in July 2026 that Prof Channa Jayasena of Imperial College London said growing online sales of unregulated drugs risk fatalities. In Australia, a coroner linked [Richard Norton's death](https://europeanpeptideshop.com/blog/richard-norton-peptide-death-coroner/) to unapproved peptides. So are peptides safe? The bodies quoted here say unregulated products carry real risks. Materials sold on this site are unlicensed and supplied for laboratory work only. ## Scope for European readers This is a dated account of the research or policy described in the linked sources. The stated jurisdiction, study product and population matter. A US or UK announcement does not establish authorisation or availability across Europe. Nothing in this report establishes results for an EPS catalogue material. Read the [research-use statement](https://europeanpeptideshop.com/research-use/) for the storefront's scope. ## Laboratory research only Materials listed on this site are supplied for in-vitro laboratory research and are not for use in or on humans or animals. They are not medicines. This article summarises published work and gives no dosing, administration, treatment or in-vivo guidance. Findings from a study apply to the material and conditions of that study, and they say nothing about any product listed here. ## References - [BCAM, 2026](https://bcam.ac.uk/media/news/64/bcam_warns_public_over_illegal_and_unregulated_peptide_injections) - [MHRA, 15 October 2026](https://www.gov.uk/government/news/counterfeit-weight-loss-pens-worth-2-million-seized-by-mhra-and-west-mids-police) - [The Guardian, 12 July 2026](https://www.theguardian.com/society/2026/jul/12/uk-wild-west-for-experimental-peptides-expert) ## More articles Research news · 2 min read ## [Australia's Synedica peptide warning](https://europeanpeptideshop.com/blog/synedica-tga-warning-australia-tb-500/) Australian testing found Synedica peptide products contained no TB-500 and less retatrutide than labelled. The TGA has told Australians to discard them. 8 November 2026 Research news · 3 min read ## [Avexitide and the LUCIDITY trial](https://europeanpeptideshop.com/blog/avexitide-glp-1-antagonist-lucidity/) Why does avexitide block GLP-1? Explore post-bariatric hypoglycemia, LUCIDITY results and Amylyx’s November 2026 FDA-filing and conference plans. 8 November 2026 Research news · 3 min read ## [BPC-157: UK and US regulatory context](https://europeanpeptideshop.com/blog/is-bpc-157-legal-in-the-uk/) The October 2026 US peptide policy is not UK authorisation. Read the MHRA classification framework and why research-use wording cannot settle a product's. 8 November 2026